For example, in the MMT-Her2 model of breast carcinoma, IL-1α deficiency delayed tumor development, probably by reduction of inflammatory microenvironment, and by reduction of cancer stem cells (CSCs) in primary tumors [28]. This evidence concerns the gene IL1A and breast carcinoma.